Ascendis Pharma A/S (ASND)

Nasdaq · Healthcare · Biotechnology
$252.73-1.26%As of 2026-11-22 · USD
Last session low $251.55Last session high $256.50
52-week low $188.0852-week high $282.15
Market cap
$16.58B
Sector
Healthcare
P/E (TTM)
16.6x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)49.4In the neutral range (30 to 70)
MACD (12, 26, 9)6.13Below its signal line (6.84); histogram -0.72
Bollinger %B (20, 2)36%Inside the bands (240.08 to 275.25)
SMA 20257.67Price is 1.9% below
SMA 50242.60Price is 4.2% above
SMA 200240.92Price is 4.9% above
ATR (20)3.02% of priceAverage true range per day
52-week position69%In the upper part of the 188.08 to 282.15 range

About Ascendis Pharma A/S

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.

Insider filings, 90 daysNo purchases and 3 sales (about $6.2M).
Latest fiscal yearEnded 2025-12-31: revenue of 720.13M EUR and an operating margin of -18.9%.

More in Biotechnology